Cohort Studymoderate evidence

Disrupted erythrocyte S1P-eNOS axis promotes hypoxia, hypertension and fibrosis in obstructive sleep apnoea-hypopnoea syndrome.

European heart journal·July 7, 2026·PMID 42412527

Why it matters

It identifies a novel RBC-centered mechanism linking intermittent hypoxia to systemic vascular injury in OSAHS, offering potential early biomarkers (sphingosine, S1P, arginine) and therapeutic targets beyond CPAP for cardiovascular and renal protection.

Infographic summary of Disrupted erythrocyte S1P-eNOS axis promotes hypoxia, hypertension and fibrosis in obstructive sleep apnoea-hypopnoea syndrome.
Visual abstract · MedLit

The papers that matter, first.

MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.

§

MedLit · Evidence, Distilled